LabCompass

Molly Downing

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2016Rising activity
Pharmaceutical Practices and Patient OutcomesMedication Adherence and CompliancePatient Safety and Medication ErrorsSafe Handling of Antineoplastic DrugsSubstance Abuse Treatment and Outcomes

Publications

10

Citations

13

Est. group size

~4

Recurring co-author estimate

Active years

11

Publishing since 2016

Research summary
AI-generated

Molly Downing's work centers on pharmacology education and medication-related safety topics, including patient outcomes tied to pharmaceutical practices, medication adherence, patient safety and medication errors, safe handling of antineoplastic (cancer-treatment) drugs, and substance abuse treatment outcomes. The available publication record is limited, with a notable gap in activity for several years followed by increased output starting in 2022.

Pharmacology educationMedication adherence and patient safetyMedication error preventionSafe handling of hazardous drugsSubstance abuse treatment outcomes

Publication activity was largely absent for much of the last decade but has increased noticeably since 2022, with a peak of 4 publications in 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
17181920212022: 1 publication22232024: 4 publications4242025: 2 publications252026: 1 publication26
Recent publications
Publishes in
  • American Journal of Pharmaceutical Education×4
  • Online Learning×1
  • Journal of American College Health×1
  • INNOVATIONS in pharmacy×1
  • The FASEB Journal×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile